Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,139 | 129,372 | 184,612 | 233,129 | 222,983 |
| Marketable Securities | 253,888 | 261,055 | 228,521 | 203,517 | 229,427 |
| Receivables | 163,896 | 119,521 | 112,993 | 133,506 | 103,480 |
| Inventories | 84,796 | 76,159 | 70,107 | 80,920 | 85,763 |
| Income taxes - deferred | 50,844 | 51,333 | 50,788 | 47,764 | 45,181 |
| TOTAL | $719,548 | $649,443 | $659,742 | $707,268 | $695,743 |
| Non-Current Assets | |||||
| PPE Net | 194,076 | 189,661 | 188,191 | 179,885 | 179,128 |
| Intangibles | 50,344 | 51,938 | 57,244 | 47,220 | 62,157 |
| Other Non-Current Assets | 94,593 | 91,163 | 91,746 | 80,447 | 72,756 |
| TOTAL | $339,013 | $332,762 | $337,181 | $307,552 | $314,041 |
| Total Assets | $1,058,561 | $982,205 | $996,923 | $1,014,820 | $1,009,784 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,614 | 27,646 | 26,824 | 25,925 | 31,057 |
| Accrued Expenses | 117,318 | 92,369 | 123,083 | 134,704 | 131,883 |
| TOTAL | $156,349 | $123,215 | $153,890 | $165,081 | $167,393 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,417 | 3,200 | 3,983 | 4,452 | 4,453 |
| Other Non-Current Liabilities | 29,738 | 29,806 | 28,563 | 26,194 | 24,256 |
| TOTAL | $33,471 | $33,806 | $32,830 | $31,042 | $30,217 |
| Total Liabilities | $189,820 | $157,021 | $186,720 | $196,123 | $197,610 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,699 | 70,057 | 69,748 | 69,557 | 68,886 |
| Common Shares | 709 | 703 | 699 | 692 | 691 |
| Retained earnings | 515,369 | 480,298 | 473,873 | 483,495 | 483,675 |
| Other shareholders' equity | 968 | -1,452 | 983 | 2,892 | 1,283 |
| TOTAL | $868,741 | $825,184 | $810,203 | $818,697 | $812,174 |
| Total Liabilities And Equity | $1,058,561 | $982,205 | $996,923 | $1,014,820 | $1,009,784 |